<SEC-DOCUMENT>0000947871-19-000488.txt : 20190702
<SEC-HEADER>0000947871-19-000488.hdr.sgml : 20190702
<ACCEPTANCE-DATETIME>20190702073906
ACCESSION NUMBER:		0000947871-19-000488
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20190702
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190702
DATE AS OF CHANGE:		20190702

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOSTON SCIENTIFIC CORP
		CENTRAL INDEX KEY:			0000885725
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042695240
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11083
		FILM NUMBER:		19935274

	BUSINESS ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
		BUSINESS PHONE:		508-683-4000

	MAIL ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ss142535_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<html>
  <head>
    <title></title>
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;" bgcolor="#ffffff" text="#000000">
  <div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: small-caps; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: small-caps; font-weight: bold;">
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center">UNITED STATES</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-variant: small-caps;">SECURITIES AND EXCHANGE COMMISSION</font></div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps;">W</font>ashington<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps;">, DC 20549</font></font></div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps;">
          <br>
        </font></font></div>
    <div style="line-height: 1.25;">
      <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 80%; color: #000000; text-align: center;" align="center" noshade="noshade"></div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-variant: small-caps;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">
          <br>
        </font></font></div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-variant: small-caps;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">FORM


          8-K</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
        </font></font><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-variant: small-caps;">CURRENT REPORT<font style="font-size: 10pt; font-family: 'Times New Roman',
          Times, serif;"><br>
        </font></font><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps;">PURSUANT


          TO SECTION 13 OR 15(</font>d<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps;">) OF THE</font></font></div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-variant: small-caps;">SECURITIES EXCHANGE ACT OF 1934&#160;</font></div>
    <div style="text-align: center; line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps;">
            <br>
          </font></font></div>
      <div style="line-height: 1.25;">
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 80%; color: #000000; text-align: center;" align="center" noshade="noshade"></div>
    </div>
    <br>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Date of Report (Date of earliest event reported): <font style="font-size: 10pt; font-family: 'Times New Roman', Times,
          serif; font-weight: bold;">July 2, 2019</font></font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 16pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><font style="font-size: 16pt; font-family: 'Times New Roman', Times, serif;"><u>BOSTON SCIENTIFIC
            CORPORATION</u></font></font></div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(Exact name of registrant as specified in its charter)</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse;" id="z31993918182d488caa8b43324902b6e5" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 42.13%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Delaware</u></font></font></div>
          </td>
          <td style="width: 25.74%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>1-11083</u></font></font></div>
          </td>
          <td style="width: 32.13%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>04-2695240</u></font></font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 42.13%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(State or other jurisdiction of incorporation)</font></div>
          </td>
          <td style="width: 25.74%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(Commission file number)</font></div>
          </td>
          <td style="width: 32.13%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(IRS employer identification no.)</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse;" id="zf23864ea329246618bc805aa47ec4767" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 82.54%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>300 Boston
                    Scientific Way, Marlborough, Massachusetts</u></font></font></div>
          </td>
          <td style="width: 17.46%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>01752-1234</u></font></font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 82.54%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(Address of principal executive offices)</font></div>
          </td>
          <td style="width: 17.46%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(Zip code)</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Registrant&#8217;s telephone number, including area code:&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times,
          serif; font-weight: bold;">(508) 683-4000</font></font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
        registrant under any of the following provisions:</font></div>
    <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> <br>
      </font></div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse;" id="z23da1ab273b14b34b3cd6c5af4262688" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 2.64%; vertical-align: bottom; text-align: center;">&#9744;</td>
          <td style="width: 97.36%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.64%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 97.36%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.64%; vertical-align: bottom; text-align: center;">&#9744;</td>
          <td style="width: 97.36%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.64%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 97.36%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.64%; vertical-align: bottom; text-align: center;">&#9744;</td>
          <td style="width: 97.36%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.64%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 97.36%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.64%; vertical-align: bottom; text-align: center;">&#9744;</td>
          <td style="width: 97.36%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> <br>
        </font></div>
      <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Securities registered pursuant to Section 12(b) of the Act:</font></div>
      <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> <br>
        </font></div>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse;" id="ze19cf022c31c46bda0298572501f0ba5" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 41.07%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;"><font style="font-size: 8pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Title of each class</font></div>
          </td>
          <td style="width: 1.46%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 15.63%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;"><font style="font-size: 8pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Trading Symbol</font></div>
          </td>
          <td style="width: 1.46%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 40.38%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;"><font style="font-size: 8pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Name of each exchange on which registered</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 41.07%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Common Stock, $0.01 par value per share</font></div>
          </td>
          <td style="width: 1.46%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 15.63%; vertical-align: top; border-top: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">BSX</font></div>
          </td>
          <td style="width: 1.46%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 40.38%; vertical-align: top; border-top: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">New York Stock Exchange</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> <br>
        </font></div>
      <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
          1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</font></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> <br>
        </font></div>
      <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Emerging growth company&#160;&#160; </font>&#9744;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> <br>
        </font></div>
      <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition
          period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160; </font>&#9744;</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center"></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;"> </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ITEM 8.01.</font>&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Other Events.</font></font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">On July 2, 2019, further to the previously announced recommended cash offer (the &#8220;<font style="font-size: 10pt;
          font-family: 'Times New Roman', Times, serif;"><u>Acquisition</u></font>&#8221;), to acquire the entire issued and to be issued ordinary share capital of BTG plc (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>BTG</u></font>&#8221;)


        by Bravo Bidco Limited, an indirect wholly-owned subsidiary of Boston Scientific Corporation (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Boston Scientific</u></font>&#8221;), BTG and Boston Scientific issued an
        announcement on the London-based Regulatory News Service (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>RNS</u></font>&#8221;), disclosing that Boston Scientific signed an agreement for the sale of its existing
        drug-eluting and bland embolic microsphere business (including ONCOZENE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup>, EMBOZENE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup>
        and EMBOZONE TANDEM<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup>) to Varian Medical Systems, Inc.<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font>The sale is subject to the
        satisfaction or waiver of customary closing conditions, including consummation of the Acquisition, and is expected to close immediately after completion of the Acquisition.</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">A copy of the aforementioned RNS announcement is attached as Exhibit 99.1 and is incorporated herein by reference;
        provided, however, that information on or connected to our website or the website of any third-party hyperlinked from or referenced in the RNS announcement included as Exhibit 99.1 to this Current Report on Form 8-K is expressly not incorporated by
        reference into or intended to be filed as a part of this Current Report on Form 8-K.</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ITEM 9.01. &#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND EXHIBITS.</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(d)&#160;&#160;Exhibits</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse;" id="zf4824330f3fd47a8a98e99f7409fc3e5" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 15%; vertical-align: top;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Exhibit No.</font></div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Description</font></div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 15%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 85%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 15%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 85%; vertical-align: top;"><br>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 15%; vertical-align: top; color: rgb(0, 0, 0);"><a href="ss142535_ex9901.htm"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">99.1</font></a></td>
          <td rowspan="1" style="width: 85%; vertical-align: top; color: rgb(0, 0, 0);"><a href="ss142535_ex9901.htm"><font style="font-size: 10pt; font-family: &quot;Times New
                Roman&quot;,Times,serif;">RNS Announcement dated July 2, 2019</font></a></td>
        </tr>

    </table>
    <br>
    <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">Further Information</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">This Form 8-K is not intended to and does not constitute or form part of any offer to sell or subscribe
        for or any invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Acquisition or otherwise nor will there be any sale, issuance or transfer of securities in any
        jurisdiction in contravention of applicable laws. The Acquisition will be implemented pursuant to the terms of the document sent to shareholders of BTG on January 24, 2019, which sets out the full details of the court-sanctioned scheme of
        arrangement under Part 26 of the United Kingdom Companies Act 2006, as amended (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Scheme Document</u></font>&#8221;), and contains the full terms and conditions of the
        Acquisition. Any decision in respect of, or other response to, the Acquisition, should be made only on the basis of the information contained in the Scheme Document.</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">SIGNATURE</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report
        to be signed on its behalf by the undersigned hereunto duly authorized.</font></div>
    <div style="text-align: left; text-indent: 216pt; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
    <div style="text-align: left; text-indent: 288pt; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse;" id="ze1598ab51e3d4f409c8dc88b81e1a6c8" cellpadding="0" cellspacing="0">

        <tr>
          <td colspan="5" style="width: 100%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.01%; vertical-align: middle;">&#160;</td>
          <td style="width: 38%; vertical-align: middle;">&#160;</td>
          <td style="width: 5%; vertical-align: middle;">&#160;</td>
          <td style="width: 39%; vertical-align: middle;">&#160;</td>
          <td style="width: 9%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td colspan="2" rowspan="1" style="width: 9.01%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: &quot;Times New Roman&quot;,Times,serif;">Date:&#160; </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">July 2, 2019</font></div>
          </td>
          <td colspan="2" style="width: 44%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">BOSTON SCIENTIFIC CORPORATION</font></div>
          </td>
          <td style="width: 9%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 9.01%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 38%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 5%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 39%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 9%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 9.01%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 38%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 5%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">By:</font></div>
          </td>
          <td style="width: 39%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">/s/ Vance R. Brown</font></div>
          </td>
          <td style="width: 9%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 9.01%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 38%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 5%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 39%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Vance R. Brown</font></div>
          </td>
          <td style="width: 9%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 9.01%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 38%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 5%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
          <td style="width: 39%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Vice President and Chief Corporate Counsel</font></div>
          </td>
          <td style="width: 9%; vertical-align: bottom;">
            <div style="text-align: left; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div><br>
      </div>
      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
      <br>
      <br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ss142535_ex9901.htm
<DESCRIPTION>RNS ANNOUNCEMENT
<TEXT>
<html>
  <head>
    <title></title>
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;" bgcolor="#ffffff" text="#000000">
  <div id="DSPFPageNumberArea" style="text-align: center;">
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY
      JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">FOR IMMEDIATE RELEASE</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">2 July 2019</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">RECOMMENDED CASH OFFER</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">for</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">BTG PLC</font></div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(BTG)</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">by</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">BRAVO BIDCO LIMITED</font></div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(Bidco)</font></div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">a newly incorporated indirect wholly-owned subsidiary of Boston Scientific Corporation (Boston
        Scientific)</font></div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">intended to be effected by means of a scheme of arrangement under Part 26 of the Companies Act</font></div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
      </font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Update on the proposed acquisition of BTG</font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
      </font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Further to the announcement regarding the proposed acquisition of BTG by Bidco, to be implemented by means of a
        Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 (the <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Acquisition</font>) released on 20 November 2018, the scheme
        circular for which was published by BTG on 24 January 2019 (the <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Scheme Document</font>), BTG and Boston Scientific are pleased to confirm that on 1
        July 2019 Boston Scientific signed an agreement for the sale of its existing drug-eluting and bland embolic microsphere business (including ONCOZENE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup>, EMBOZENE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> and EMBOZONE TANDEM<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup>) to Varian Medical Systems, Inc. The sale is subject to the
        satisfaction or waiver of customary closing conditions, including consummation of the Acquisition, and is expected to close immediately after completion of the Acquisition<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;
          font-weight: bold; font-style: italic;">.</font></font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> <br>
      </font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">The Acquisition has received merger control clearance in Germany under the German Act Against Restraints of Competition
        and the Taiwan Fair Trade Commission has terminated its investigation. The Scheme remains subject to the satisfaction or (if capable of waiver) waiver of the remaining Conditions set out in the Scheme Document, including the Court&#8217;s sanction of the
        Scheme at the Court Hearing and the delivery of an office copy of the Court Order to the Registrar of Companies.</font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> <br>
      </font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">The current expected timetable of principal events for the implementation of the Scheme is set out below. All references
        in this announcement to time are to London times unless otherwise stated. The dates and times given are indicative only and are based on BTG&#8217;s current expectations and may be subject to change (including as a result of changes to the regulatory
        timetable). If any of the key dates set out in the expected timetable changes, an announcement will be made through a Regulatory Information Service:</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse;" id="z854a941dcb1545e0982f5d2157cc069f" border="0" cellpadding="3" cellspacing="0">

        <tr>
          <td colspan="2" style="width: 100%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">The following dates are indicative only and are subject to change:</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.99%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Court Hearing</font></div>
          </td>
          <td style="width: 50.01%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">15 August 2019</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.99%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Last day of dealings in BTG Shares</font></div>
          </td>
          <td style="width: 50.01%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">16 August 2019</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.99%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Dealings in BTG Shares suspended in London</font></div>
          </td>
          <td style="width: 50.01%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">5.00 p.m. on 16 August 2019</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.99%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Scheme Record Time</font></div>
          </td>
          <td style="width: 50.01%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">6.00 p.m. on 16 August 2019</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.99%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Effective Date of the Scheme</font></div>
          </td>
          <td style="width: 50.01%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">19 August 2019</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.99%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Delisting of BTG Shares</font></div>
          </td>
          <td style="width: 50.01%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">By 8.00 a.m. on 20 August 2019</font></div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.99%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Despatch of cheques and crediting of CREST for Cash Consideration due under the Scheme</font></div>
          </td>
          <td style="width: 50.01%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">By 2 September 2019</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.99%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Long Stop Date</font></div>
          </td>
          <td style="width: 50.01%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">20 August 2019<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></font></div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: -18.15pt; margin-left: 18.15pt; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;"> <br>
      </font></div>
    <div style="text-align: justify; text-indent: -18.15pt; margin-left: 18.15pt; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Note:</font></div>
    <div style="text-align: justify; text-indent: -18.15pt; margin-left: 18.15pt; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;"> <br>
      </font></div>
    <div style="text-align: justify; line-height: 1.25;">
      <div>
        <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;" class="DSPFListTable" id="zb0d78c6d6f8c4967a17f8182acad1189" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right;"><font style="font-size: 8pt; font-family: 'Times New Roman', Times, serif;">&#160;(1)</font></td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-size: 8pt; font-family: 'Times New Roman', Times, serif;">This is the latest date by which the Scheme may become Effective unless Boston Scientific and BTG agree (and the Panel and, if required, the Court permit) a
                    later date.</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
      </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">1</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Other</font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> <br>
      </font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Terms defined in the Scheme Document have the same meanings in this announcement.</font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> <br>
      </font></div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">A copy of this announcement will be available on BTG&#8217;s website at <font style="font-size: 10pt; color: rgb(0, 0, 0);">www.btgplc.com</font>,
        subject to certain restrictions relating to persons resident in in Restricted Jurisdictions.</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse;" id="zabc27b18ad964b6e8057f0fc310998d0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 70.88%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Enquiries:</font></div>
          </td>
          <td style="width: 29.12%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 70.88%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 29.12%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 70.88%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">BTG</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Andy Burrows (Vice President, Corporate &amp; Investor Relations)</font></div>
          </td>
          <td style="width: 29.12%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">+44 20 7575 1741</font></div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 70.88%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 29.12%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 70.88%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Goldman Sachs International (joint financial adviser to BTG)</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Anthony Gutman</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Nimesh Khiroya</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">S&#248;ren&#160;Moller-Rasmussen</font></div>
          </td>
          <td style="width: 29.12%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">+44 20 7774 1000</font></div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 70.88%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 29.12%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 70.88%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">J.P. Morgan Cazenove (joint financial adviser</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">and joint corporate broker to BTG)</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">James Mitford</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Dwayne Lysaght</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Alex Bruce</font></div>
          </td>
          <td style="width: 29.12%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">+44 20 7742 4000</font></div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 70.88%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 29.12%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 70.88%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Rothschild &amp; Co (joint financial adviser to BTG)</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Richard Murley</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Dominic Hollamby</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Julian Hudson</font></div>
          </td>
          <td style="width: 29.12%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">+44 20 7280 5000</font></div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 70.88%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 29.12%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 70.88%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Deutsche Bank AG (joint corporate broker to BTG)</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Neil Collingridge</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Seth Damergy</font></div>
          </td>
          <td style="width: 29.12%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">+44 20 7545 8000</font></div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 70.88%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 29.12%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 70.88%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">FTI Consulting (PR adviser to BTG)</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Ben Atwell</font></div>
          </td>
          <td style="width: 29.12%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">+44 20 3727 1000</font></div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 70.88%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 29.12%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 70.88%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Bidco / Boston Scientific</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Susie Lisa (Investor Relations)</font></div>
          </td>
          <td style="width: 29.12%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">+1 (508) 683-5565</font></div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 70.88%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 29.12%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 70.88%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Barclays (financial adviser to Bidco and Boston Scientific)</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Doug Solomon</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Jed Brody</font></div>
            <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Derek Shakespeare</font></div>
          </td>
          <td style="width: 29.12%; vertical-align: top;">
            <div style="text-align: right; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">+44 20 7623 2323</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">2</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Important notices relating to Financial Advisers</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">Goldman Sachs International, which is authorised by the Prudential Regulation Authority and regulated
        by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting exclusively for BTG and no one else in connection with the Acquisition and any other matters referred to in this Announcement and will not
        be responsible to anyone other than BTG for providing the protections afforded to such financial advisory clients of Goldman Sachs International, or for providing advice in connection with Acquisition or any matters referred to in this
        Announcement.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove
        (<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">J.P. Morgan Cazenove</font>), is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential
        Regulation Authority in the United Kingdom. J.P. Morgan Cazenove is acting as financial advisor exclusively for BTG and no one else in connection with the Acquisition and any other matters referred to in this Announcement and will not be
        responsible to anyone other than BTG for providing the protections afforded to such financial advisory clients of J.P. Morgan Cazenove, or for providing advice in relation to the Acquisition or any matter referred to in this Announcement.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">N M Rothschild &amp; Sons Limited (<font style="font-size: 10pt; font-family: 'Times New Roman',
          Times, serif; font-weight: bold;">Rothschild &amp; Co</font>), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively for BTG and no one else in connection with the matters set out in
        this Announcement and will not regard any other person as its client in relation to the matters set out in this Announcement and will not be responsible to anyone other than BTG for providing the protections afforded to clients of Rothschild &amp;
        Co, nor for providing advice in relation to the Acquisition or any other matter referred to in this Announcement. Neither Rothschild &amp; Co nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility
        whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Rothschild &amp; Co in connection with the matters referred to in this Announcement, or otherwise.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">Deutsche Bank AG is
          authorised under German Banking Law (competent authority: European Central Bank) and, in the United Kingdom, by the Prudential Regulation Authority. It is subject to supervision by the European Central Bank and by BaFin, Germany&#8217;s Federal
          Financial Supervisory Authority, and is subject to limited regulation in the United Kingdom by the Prudential Regulation Authority and Financial Conduct Authority. Details about the extent of its authorisation and regulation by the Prudential
          Regulation Authority, and regulation by the FCA, are available on request or from&#160;</font>www.db.com/en/content/eu_disclosures.htm<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">. Deutsche Bank AG,
          acting through its London branch (</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Deutsche Bank</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times,
          serif; font-style: italic;">) is acting as Corporate Broker to&#160;BTG plc and no other person in connection with this Announcement or any of its contents. Deutsche Bank will not be responsible to any person other than&#160;BTG plc for providing any of
          the protections afforded to clients of Deutsche Bank, nor for providing any advice in relation to the matters set out in this Announcement. Neither Deutsche Bank nor any of its affiliates owes or accepts any duty, liability or responsibility
          whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Deutsche Bank in connection with the matters set out in this Announcement, any statement contained herein or
          otherwise.</font></font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">Barclays Bank PLC, acting through its investment bank (<font style="font-size: 10pt; font-family:
          'Times New Roman', Times, serif; font-weight: bold;">Barclays</font>), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is
        acting exclusively for Boston Scientific and Bidco and no one else in connection with the matters referred to in this Announcement and will not be responsible to anyone other than Boston Scientific and Bidco for providing the protections afforded
        to clients of Barclays nor for providing advice in relation to the Acquisition or any other matter referred to in this Announcement.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">3</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Further Information</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">This Announcement is for information purposes only and is not intended to, and does not, constitute or
        form part of any offer, invitation, inducement or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of or exercise rights in respect of any securities, or the solicitation of any vote or approval
        of an offer to buy securities in any jurisdiction, pursuant to the Acquisition or otherwise nor shall there be any sale, issuance or transfer of any securities pursuant to the Acquisition in any jurisdiction in contravention of any applicable laws.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">The Acquisition is being made solely through the Scheme Document (unless Boston Scientific elects,
        with the consent of the Panel, to implement the Acquisition by way of a Takeover Offer), which contains the full terms and conditions of the Acquisition, including details of how to vote at the Meetings in respect of the Scheme. Any decision to
        vote or other response in respect of the Acquisition should be made only on the basis of the information contained in the Scheme Document. BTG Shareholders are advised to read the Scheme Document carefully.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">This Announcement does not constitute a prospectus or prospectus-equivalent document.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">This Announcement has been prepared for the purpose of complying with English law and the Code and the
        information disclosed may not be the same as that which would have been disclosed if this Announcement had been prepared in accordance with the laws of jurisdictions outside the United Kingdom.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">In accordance with the Code, normal United Kingdom market practice and Rule 14e-5(b) of the Exchange
        Act, Barclays and its affiliates will continue to act as an exempt principal trader in BTG securities on the London Stock Exchange. The purchases and activities by exempt principal traders which are required to be made public in the United Kingdom
        pursuant to the Code will be reported to a Regulatory Information Service and will be available on the London Stock Exchange website at www.londonstockexchange.com. This information will also be publicly disclosed in the US to the extent that such
        information is made public in the United Kingdom.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Overseas jurisdictions</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">The release, publication or distribution of this Announcement in, and the availability of the
        Acquisition to persons who are residents, citizens or nationals of jurisdictions other than the United Kingdom may be restricted by laws and/or regulations of those jurisdictions. In particular, the ability of persons who are not resident in the
        United Kingdom or who are subject to the laws of another jurisdiction to vote their Scheme Shares with respect to the Scheme at the Court Meeting, or to execute and deliver Forms of Proxy appointing another to vote at the Court Meeting on their
        behalf, may be affected by the laws of the relevant jurisdictions in which they are located. Therefore, any persons not resident in the United Kingdom and/or<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight:
          bold;">&#160;</font>who are subject to the laws and regulations of any jurisdiction other than the United Kingdom should inform themselves about, and observe, any applicable legal and regulatory requirements. Any failure to comply with the applicable
        requirements may constitute a violation of the laws and/or regulations of any such jurisdiction.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">The Acquisition will not be made, directly or indirectly, in, into or from a Restricted Jurisdiction
        where to do so would violate the laws of that jurisdiction and no person may vote in favour of the Acquisition by any use, means, instrumentality or form within a Restricted Jurisdiction or any other jurisdiction if to do so would constitute a
        violation of the laws of that jurisdiction. Accordingly, copies of this Announcement and any formal documentation relating to the Acquisition are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent
        in or into or from any Restricted Jurisdiction and persons receiving such documents (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send them in or into or from any Restricted Jurisdiction.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">4</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">The receipt of cash pursuant to the Acquisition by BTG Shareholders may be a taxable transaction under
        applicable national, state and local, as well as foreign and other tax laws. Each BTG Shareholder is urged to consult their independent professional adviser regarding the tax consequences of the Acquisition applicable to him.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">If the Acquisition is implemented by way of a Takeover Offer (unless otherwise permitted by applicable
        law and regulation), the Takeover Offer may not be made, directly or indirectly, in, into or by use of the mails or any other means of instrumentality (including, without limitation, facsimile, e-mail or other electronic transmission, telex or
        telephone) of interstate or foreign commerce of, or any facility of a national, state or other securities exchange of any Restricted Jurisdiction and the Takeover Offer will not be capable of acceptance by any such use, means, instrumentality or
        facilities or from within any Restricted Jurisdiction where to do so would violate the laws of that jurisdiction<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#160;</font>and shall not be capable of
        acceptance by any such use, means, instrumentality or facility or from within such Restricted Jurisdiction.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">This Announcement has been prepared for the purpose of complying with English law, the rules of the
        London Stock Exchange and the Code and the information disclosed may not be the same as that which would have been disclosed if this Announcement has been prepared in accordance with the laws of jurisdictions outside England and Wales.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">Further details in relation to BTG Shareholders in overseas jurisdictions will be contained in the
        Scheme Document.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Notice to US Investors in BTG</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">The Acquisition relates to the shares of a company organised under the laws of England and Wales and
        is proposed to be effected by means of a scheme of arrangement under the laws of England and Wales (Part 26 of the Companies Act). This Announcement, the Scheme Document and certain other documents relating to the Acquisition have been or will be
        prepared in accordance with English law, the Code and UK disclosure requirements, format and style, all of which differ from those in the United States. A transaction effected by means of a scheme of arrangement is not subject to the tender offer
        rules or the proxy solicitation rules under the US Securities Exchange Act of 1934, as amended (the <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">US Exchange Act</font>). Accordingly, the
        Acquisition is subject to the disclosure requirements of and practices applicable in the United Kingdom to schemes of arrangement involving a target company in England listed on the London Stock Exchange, which differ from the disclosure
        requirements of the United States tender offer and proxy solicitation rules. Bidco reserves the right, subject to the prior consent of the Panel, to elect to implement the Acquisition by way of a Takeover Offer. If, in the future, Bidco exercises
        its right to implement the Acquisition by way of a Takeover Offer and determines to extend the Takeover Offer into the United States, such offer and the Acquisition will be made in compliance with applicable US tender offer regulations.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">If the Acquisition is implemented by way of a Takeover Offer, pursuant to Rule 14e-5(b) under the US
        Exchange Act, Bidco, certain affiliated companies or their nominees or brokers (acting as agents) may from time to time make certain purchases of, or arrangements to purchase, shares in BTG outside such a Takeover Offer during the period in which
        such a Takeover Offer would remain open for acceptance. If such purchases or arrangements to purchase were to be made, they would be made outside the US and would apply in accordance with applicable law, including the US Exchange Act and the Code.
        Such purchases may occur either in the open market at prevailing prices or in private transactions at negotiated prices. Any information about such purchases will be disclosed as required in the United Kingdom, will be reported to the Regulatory
        News Service of the London Stock Exchange and will be available on the London Stock Exchange website at: http://www.londonstockexchange.com/prices-and-news/prices-news/home.htm.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">BTG&#8217;s financial statements, and all financial information that is included in this Announcement or
        that may be included in the Scheme Document, or any other documents relating to the Acquisition, have been or will be prepared in accordance with non-US accounting standards that may not be comparable to financial information of companies in the
        United States or other companies whose financial statements are prepared in accordance with US generally accepted accounting principles.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">5</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">Neither the United States Securities and Exchange Commission nor any US state securities commission
        has approved or disapproved the Acquisition, passed upon the merits or fairness of the Acquisition or passed any opinion upon the accuracy, adequacy or completeness of this Announcement or the Scheme Document. Any representation to the contrary is
        a criminal offence in the United States.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">BTG is incorporated under the laws of England and Wales. In addition, some of its officers and
        directors reside outside the United States, and some or all of its assets are or may be located in jurisdictions outside the United States. Therefore, investors may have difficulty effecting service of process within the United States upon those
        persons or recovering against BTG or its officers or directors on judgments of United States courts, including judgments based upon the civil liability provisions of the United States federal securities laws. It may not be possible to sue BTG or
        its officers or directors in a non-U.S. court for violations of the U.S. securities laws.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">The receipt of cash pursuant to the Acquisition by US holders of BTG Shares as consideration for the
        transfer of its Scheme Shares pursuant to the Scheme may be a taxable transaction for US federal income tax purposes and under applicable US state and local, as well as foreign and other, tax laws. Each US holder of BTG Shares is urged to consult
        his or her independent professional adviser immediately regarding the tax consequences of the Acquisition applicable to him or her.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Publication on website and availability of hard copies</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">This Announcement and the display documents required to be published pursuant to Rule 26.1 of the Code
        will be made available, free of charge and subject to certain restrictions relating to persons in Restricted Jurisdictions, on BTG&#8217;s website at www.btgplc.com and Boston Scientific&#8217;s website at http://investors.bostonscientific.com by no later than
        12 noon (London time) on the business day following the date of this Announcement. For the avoidance of doubt, neither the content of such website nor the content of any other website accessible from hyperlinks on such websites is incorporated
        into, nor forms part of, this Announcement.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">In accordance with Rule 30.3 of the Code, a person so entitled may request a copy of this Announcement
        (and any information incorporated into it by reference to another source) in hard copy form by writing to Link Asset Services, The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU or by calling the Shareholder Helpline at Link Asset Services on
        +44 (0) 371 664 0321. Calls are charged at the standard geographic rate and will vary by provider. Calls from outside the UK will be charged at the applicable international rate. Link Asset Services is open from 9:00 a.m. to 5.30 p.m., Monday to
        Friday, excluding public holidays in England and Wales. Please note that Link Asset Services cannot provide financial, legal or tax advice and calls may be recorded and monitored for security and training purposes.&#160; Such person may also request
        that all future documents announcements and information sent to that person in relation to the Acquisition should be in hard copy form. Save as otherwise referred to above, a hard copy of this Announcement will not be sent unless requested.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">General</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">If you are in any doubt about the contents of this Announcement or the action you should take, you are
        recommended to seek your own independent financial advice immediately from your stockbroker, bank manager, solicitor or independent financial adviser duly authorised under the Financial Services and Markets Act 2000 (as amended) if you are resident
        in the United Kingdom or, if not, from another appropriate authorised independent financial adviser.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">6</font></div>
  <div id="DSPFPageNumberArea" style="text-align: center;">
    <div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
    </div>
    <font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;"> </font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
